Faye Vazvaei

776 total citations
18 papers, 457 citations indexed

About

Faye Vazvaei is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Faye Vazvaei has authored 18 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Faye Vazvaei's work include Biosimilars and Bioanalytical Methods (9 papers), Protein purification and stability (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Faye Vazvaei is often cited by papers focused on Biosimilars and Bioanalytical Methods (9 papers), Protein purification and stability (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Faye Vazvaei collaborates with scholars based in United States, Switzerland and United Kingdom. Faye Vazvaei's co-authors include Jeffrey X. Duggan, Rand Jenkins, Ziping Yang, Dawn Dufield, Surinder Kaur, John S. Yu, Gary A. Schultz, Yan J Zhang, Anne‐Françoise Aubry and Fabio Garofolo and has published in prestigious journals such as Analytical Chemistry, Cancer Research and Neuro-Oncology.

In The Last Decade

Faye Vazvaei

18 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faye Vazvaei United States 11 237 134 110 97 79 18 457
Carola W.N. Damen Netherlands 14 361 1.5× 113 0.8× 122 1.1× 173 1.8× 184 2.3× 17 575
Craig Titsch United States 9 202 0.9× 99 0.7× 99 0.9× 98 1.0× 38 0.5× 11 351
Marianne Schmidt Germany 17 398 1.7× 29 0.2× 155 1.4× 37 0.4× 35 0.4× 39 712
Eszter Csánky Hungary 11 268 1.1× 86 0.6× 44 0.4× 63 0.6× 56 0.7× 29 459
Ronak Tilvawala United States 12 240 1.0× 211 1.6× 76 0.7× 34 0.4× 21 0.3× 20 605
Eckart Köttgen Germany 16 426 1.8× 103 0.8× 110 1.0× 39 0.4× 71 0.9× 32 746
Martina Chang Austria 8 328 1.4× 35 0.3× 68 0.6× 43 0.4× 63 0.8× 10 467
Richard Tacey United States 7 309 1.3× 367 2.7× 74 0.7× 227 2.3× 18 0.2× 7 602
Jie Mao China 14 311 1.3× 100 0.7× 77 0.7× 23 0.2× 33 0.4× 40 565
Shuzhen Wu China 12 370 1.6× 76 0.6× 55 0.5× 33 0.3× 274 3.5× 26 584

Countries citing papers authored by Faye Vazvaei

Since Specialization
Citations

This map shows the geographic impact of Faye Vazvaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faye Vazvaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faye Vazvaei more than expected).

Fields of papers citing papers by Faye Vazvaei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faye Vazvaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faye Vazvaei. The network helps show where Faye Vazvaei may publish in the future.

Co-authorship network of co-authors of Faye Vazvaei

This figure shows the co-authorship network connecting the top 25 collaborators of Faye Vazvaei. A scholar is included among the top collaborators of Faye Vazvaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faye Vazvaei. Faye Vazvaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hays, Amanda, Lakshmi Amaravadi, Carmen Fernández‐Metzler, et al.. (2022). Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays?. The AAPS Journal. 24(3). 65–65. 1 indexed citations
2.
An, Bo, Yang Qu, Shichen Shen, et al.. (2020). Toward Accurate and Robust Liquid Chromatography–Mass Spectrometry-Based Quantification of Antibody Biotherapeutics in Tissues. Analytical Chemistry. 92(22). 15152–15161. 10 indexed citations
3.
Roadcap, Brad, Azher Hussain, Yang Xu, et al.. (2020). Clinical Application of Volumetric Absorptive Microsampling to the Gefapixant Development Program. Bioanalysis. 12(13). 893–904. 20 indexed citations
4.
Fischer, Holger, Mohammed Ullah, Cecile C. de la Cruz, et al.. (2020). Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein. Neuro-Oncology. 22(6). 819–829. 65 indexed citations
5.
6.
Booth, Brian, Faye Vazvaei, Eric Fluhler, Heather Myler, & Eric Woolf. (2019). AAPS Workshop Report on ICH M10. The AAPS Journal. 22(1). 10–10. 5 indexed citations
7.
8.
Cruz, Cecile C. de la, Thomas Hunsaker, Faye Vazvaei, et al.. (2019). Abstract 3894: Determination of the efficacious Entrectinib exposures required for pathway inhibition and anti-tumor activity in a subcutaneous and intracranialTPM3-NTRK1mutant tumor model. Cancer Research. 79(13_Supplement). 3894–3894. 3 indexed citations
9.
Nemunaitis, John, Annie Young, Samuel Ejadi, et al.. (2018). Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 81(3). 529–537. 16 indexed citations
10.
Vazvaei, Faye & Philip Timmerman. (2018). Incurred Sample Reproducibility. Bioanalysis. 10(21). 1705–1706. 1 indexed citations
11.
Morcos, Peter N., Yumi Cleary, Elena Guerini, et al.. (2018). Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib. The Journal of Clinical Pharmacology. 58(12). 1618–1628. 19 indexed citations
12.
Zhang, Ming, Bo An, Yang Qu, et al.. (2017). Sensitive, High-Throughput, and Robust Trapping-Micro-LC-MS Strategy for the Quantification of Biomarkers and Antibody Biotherapeutics. Analytical Chemistry. 90(3). 1870–1880. 34 indexed citations
13.
Glenn, Kelli, Li Yu, Micaela B. Reddy, et al.. (2015). Investigating the effect of autoinduction in cynomolgus monkeys of a novel anticancer MDM2 antagonist, idasanutlin, and relevance to humans. Xenobiotica. 46(8). 667–676. 9 indexed citations
14.
Duggan, Jeffrey X., Faye Vazvaei, & Rand Jenkins. (2015). Bioanalytical Method Validation Considerations for LC–MS/MS Assays of Therapeutic Proteins. Bioanalysis. 7(11). 1389–1395. 29 indexed citations
15.
Fluhler, Eric, Faye Vazvaei, Puran Singhal, et al.. (2014). Repeat Analysis and Incurred Sample Reanalysis: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team. The AAPS Journal. 16(6). 1167–1174. 34 indexed citations
16.
17.
Jenkins, Rand, Jeffrey X. Duggan, Anne‐Françoise Aubry, et al.. (2014). Recommendations for Validation of LC-MS/MS Bioanalytical Methods for Protein Biotherapeutics. The AAPS Journal. 17(1). 1–16. 140 indexed citations
18.
Vazvaei, Faye, Paul Weigl, Hilde Rosing, et al.. (2005). Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high‐performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 19(24). 3673–3680. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carola W.N. Damen Breakdown of academic impact, for papers by Craig Titsch Breakdown of academic impact, for papers by Marianne Schmidt Breakdown of academic impact, for papers by Eszter Csánky Breakdown of academic impact, for papers by Ronak Tilvawala Breakdown of academic impact, for papers by Eckart Köttgen Breakdown of academic impact, for papers by Martina Chang Breakdown of academic impact, for papers by Richard Tacey Breakdown of academic impact, for papers by Jie Mao Breakdown of academic impact, for papers by Shuzhen Wu
Rankless by CCL
2026